VICP — Vicapsys Life Sciences, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1468639 ·
Last close
$0.55
Market Cap
$17.80M
52W High
$1.77
52W Low
$0.11
ADV30
1,930
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2024 | 0 | — | -198,862 | -235,507 | 89,569 | 89,569 | 2,735,296 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-40,431
Investing CF
—
Financing CF
$130,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.01
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-17,052,745
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-198,862
Pretax Income TTM
$-235,507
Interest Exp TTM
$36,645
Analysts
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2023 | 0 | -1,046,978 | -1,182,112 | 39,656 | 1,968,337 | -1,928,681 | -417,524 |
| Dec 2022 | 0 | -644,559 | -984,790 | 72,021 | 1,022,812 | -950,791 | -238,197 |
| Dec 2021 | 0 | -336,871 | -236,871 | 594,313 | 715,964 | -121,651 | -443,974 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-1,347,472
OpCashFlow TTM
—
Assets (Latest)
$89,569
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NCEL | NewcelX Ltd. | $17.59M | $3.05 | — |
| NEUP | Neuphoria Therapeutics Inc. | $18.16M | $3.36 | — |
| INTI | Inhibitor Therapeutics, Inc. | $17.13M | $0.10 | — |
| AKTX | Akari Therapeutics Plc | $17.08M | $8.77 | — |
| QNTM | Quantum Biopharma Ltd. | $18.90M | $2.94 | — |
News headlines (Yahoo Finance, 1h cache)
Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary
2026-10-05 12:00 · Yahoo
Vicapsys Life Sciences Announces Advisory Board Following Completion of Stateline Merger
2026-09-25 14:05 · Yahoo
RETRANSMISSION: Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Phar
2026-09-23 12:30 · Yahoo
Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manuf
2026-09-22 16:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.